VKI has a total leverage of 39% The expense ratio is 3.44% and the non-leverage expense ratio is 0.96%. The fund's 6-month ...

Wall Street’s recent rally has propelled major U.S. stock benchmarks to record territory, with the S&P 500 (SP500) posting a ...

The Spot Solana ETF approval odds are at their peak, at 99% or higher, as the SEC acknowledges another filing. Here’s when it ...

The stock market is back where it started. The S&P 500 was down 0.3% after getting its head above water for a few gasps of air. The Nasdaq Composite was down 0.3%. The Dow was down 180 points, or 0.4% ...

The SEC continues to chug along nicely under the crypto-friendly regime led by new chair Paul Atkins. The agency’s latest ...

The Orange Blossom Classic Committee officially launched the countdown to the 2025 Invesco QQQ Orange Blossom Classic with a ...

The biotechnology industry is split between two very different types of companies. On one side are the large, blue-chip leaders like Amgen Inc. (ticker: AMGN), Gilead Sciences Inc.

Invesco Ltd. significantly ramped up its investment in PayPal Holdings, Inc., increasing its shares by 14.9%. The firm now ...

Dallas developer Stonelake Capital Partners remains big player in El Paso industrial market after it sells 7 buildings for ...

The Invesco QQQ Trust is an index-tracking exchange-traded fund (ETF). The index it follows is the Nasdaq 100. They can ...